Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Top Cited Papers
- 1 February 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 375 (9713), 463-474
- https://doi.org/10.1016/s0140-6736(09)61879-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised studyEuropean Respiratory Journal, 2009
- Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialCritical Care, 2009
- Issues in Noninferiority Trials: The Evidence in Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- Antibiotic Treatment of Exacerbations of COPDChest, 2007
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyBMJ, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid TreatmentsAntimicrobial Agents and Chemotherapy, 2003